2 Neuroscience2.5 Neurochemistry and neurophysiology

2.5.2.5 Neuropeptides, the endocannabinoid system and orexins

2 min read1 figure

Written by Resident Doctor Committee · Published

How neuropeptides differ from classical transmitters

Neuropeptides are the large-molecule transmitters, chains of amino acids, whereas classical transmitters are small molecules.

Feature

Small-molecule transmitter

Neuropeptide

Endocannabinoid

Where made

At the terminal, and recycled there

Precursor in the cell body

Membrane lipid, made on demand

Storage

Synaptic vesicles

Dense core vesicles

Not stored in vesicles

Receptors

Ionotropic or metabotropic

Mainly G-protein-coupled

Cannabinoid receptors

How the signal ends

Reuptake, metabolism and diffusion

Peptidases and diffusion

Enzyme breakdown

Follow the orange route: a neuropeptide such as substance P is made as a precursor in the cell body and carried in dense-core vesicles to the terminal, then broken down by peptidases after release, whereas the blue small-molecule transmitter is made in the terminal and recycled by reuptake. Drawn for MRCPsychiatrist

Opioid peptides

Precursor

Peptide

Preferred receptor

Proenkephalin

Met- and leu-enkephalin

Delta, with mu activity

Pro-opiomelanocortin

Beta-endorphin

Mu and delta

Prodynorphin

Dynorphin

Kappa

  • Dynorphin is released by stress, and kappa activation causes dysphoria and anhedonia, so kappa antagonists have been studied in depression.

Substance P

  • Substance P is a tachykinin that binds the neurokinin-1 (NK1) receptor with highest affinity.

  • NK1 blockade was tried as an antidepressant, with disappointing trials, and the NK1 antagonist aprepitant is now used as an antiemetic.

Vasopressin and oxytocin

  • Vasopressin (antidiuretic hormone) is made in the supraoptic and paraventricular nuclei and released from the posterior pituitary.

  • At renal V2 receptors it moves aquaporin-2 channels into the collecting duct, so the kidney retains water.

  • Oxytocin is a nonapeptide that differs from vasopressin at two amino acids.

  • Both peptides act as central neurotransmitters released by neurones and as hormones secreted into the blood.

Orexins

  • Orexin-A and orexin-B (hypocretin-1 and hypocretin-2) are made only by lateral hypothalamic neurones and couple arousal to appetite and energy state.

  • Narcolepsy type 1 follows loss of orexin cells and shows cataplexy and low cerebrospinal fluid orexin.

  • Orexin receptor antagonists such as daridorexant treat insomnia.

Endocannabinoids

  • Anandamide and 2-arachidonoylglycerol are released by the postsynaptic cell and act backwards on presynaptic CB1 receptors to reduce gamma-aminobutyric acid or glutamate release.

  • CB1 is widespread in memory, movement and reward circuits, whereas CB2 is mainly involved in immune signalling.